Aveir VR Leadless Pacemaker | Abbott
CARDIOVASCULAR
hamburger
Aveir VR

 

CHRONIC RETRIEVAL

chronic outline

 Aveir VRTM Leadless Pacemaker’s helical fixation is designed for chronic retrieval, expanding therapeutic options.1,2*

 

 

LONG LASTING

battery outline

Battery is projected to offer up to twice the longevity of current VR leadless pacemakers based on ISO standard settings.1,3**

 

MAPPING PRIOR TO FIXATION

target outline

Aveir VR Leadless Pacemaker mapping capability is designed to help reduce the number of repositioning attempts.1,4
 

 

DOWNLOAD THE PHYSICIAN BROCHURE TO SEE
 ALL AVEIR VR LEADLESS PACEMAKER HAS TO OFFER

 

LIFE-CHANGING INNOVATION

DUAL-CHAMBER SYSTEM EXPANDABILITY

The software for Aveir VR Leadless Pacemaker was designed for expandability to a dual chamber system to be introduced to the Aveir VR system via software updates in the future, upon regulatory approval.1***

outline of heart

AVEIR IS 1.5T AND 3T MR CONDITIONAL

Aveir is MR Conditional for full body scans using a 1.5T or 3T field strength MRI scanner.****

MR triangle

VIEW THE CLINICAL STUDY

SEE THE INNOVATIONS BEHIND AVEIR LEADLESS PACEMAKER

References

* Limited data is available for Aveir Leadless Pacemaker. The Aveir Leadless Pacemaker’s predicate device has chronic retrieval success rate >80% with helix fixation through 7 years regardless of implant duration
** ISO standard settings: VVIR, 60bpm, 2.5V @0.4 ms, 600 Ω, 100% pacing
*** ASIC chip designed to provide an expandable platform to later support a dual chamber pacing system once approved
**** Stability of pacing capture thresholds 
is required prior to MRI scan. For additional information about specific MR Conditional, including warnings, precautions, adverse conditions to MRI scanning and potential adverse events, please refer to the MRI-Ready Leadless Systems Manual at medical.abbott/manuals or check our MRI Ready resources at cardiovascular.abbott/mriready

  1. Aveir™ VR Leadless Pacemaker and Delivery Catheter IFU. ARTEN600175956
  2. Reddy VY, et al. Chronic Retrievability with a Leadless Pacemaker: A Worldwide Nanostim Experience out of 7y. Presented at: HRS 2021; Jul 28-31, 2021; Boston, MA.
  3. Micra‡ VR IFU M991010A001 REV. B
  4. Reddy, VY et al. Primary Results on Safety and Efficacy from the LEADLESS II-Phase 2 Worldwide Clinical Trial, JACC: Clinical Electrophysiology, 2021, ISSN 2405-500X, https://doi.org/10.1016/j.jacep.2021.11.002.

                                                                          

MAT-2112095 v2.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.